Gray-market vendor describes a supplier operating in the gap between legitimate research supply and unlicensed pharmaceutical distribution. The material may be genuine and the label may say research use only, but the surrounding presentation is aimed at personal administration. The distinction is not about price or brand recognition; it is about what the seller is actually offering.
Identifiable red flags
Human framing is the clearest: administration schedules, protocol guides, before-and-after imagery, or customer testimonials describing personal use. Then documentation: a certificate of analysis with no lot number, no analysis date, no named laboratory, or the same PDF reused across unrelated products — the recycled-COA pattern is common and easy to check. Then traceability: no way to match the vial in hand to a specific tested batch.
Further signals include prescription-only molecules listed for open sale, purity figures quoted without an HPLC chromatogram or MS trace, absent storage and shipping conditions, and payment routes that leave the buyer with no recourse.
The practical defence is documentary: demand lot-matched analytics and confirm them, ideally through independent testing.
Related terms and material
FDA-approved vs research-grade · compounding pharmacy · purity. Further reading: vendor checklist and choosing a research peptide vendor.